Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 180.20 EUR | -2.96% |
|
-1.69% | -14.19% |
| 07-20 | Zonebourse corporate earnings calendar: week of July 20 to 24, 2026 |  |
| 07-16 | MedTech facing a three-front squeeze |  |
| Market Cap | 17.53B 20B 16.21B 14.9B 28.16B 1,930B 28.59B 194B 75.91B 945B 75.14B 73.49B 3,250B | P/E 2026 * |
45.8x | P/E 2027 * | 36x |
|---|---|---|---|---|---|
| Enterprise Value | 19.55B 22.3B 18.07B 16.61B 31.39B 2,152B 31.87B 216B 84.62B 1,053B 83.77B 81.92B 3,624B | EV / Sales 2026 * |
6.18x | EV / Sales 2027 * | 5.52x |
| Free-Float |
28.47% | Yield 2026 * |
0.47% | Yield 2027 * | 0.57% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | -2.96% | ||
| 1 week | -1.69% | ||
| Current month | -0.77% | ||
| 1 month | +10.35% | ||
| 3 months | -4.50% | ||
| 6 months | -12.65% | ||
| Current year | -14.19% |
| 1 week | 179.9 |  | 190.8 |
| 1 month | 160.4 | | 190.8 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 287.8 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.96% | -1.69% | -5.33% | -24.16% | 20.68B | |
| +0.97% | +8.23% | -17.80% | -5.24% | 175B | |
| +0.11% | -0.69% | -7.05% | -3.29% | 106B | |
| -1.27% | +0.18% | +3.80% | +58.38% | 59.91B | |
| +0.66% | +0.96% | +37.64% | +54.22% | 51.95B | |
| -2.33% | +1.67% | -13.63% | -39.40% | 43.58B | |
| -2.29% | -5.26% | - | - | 33.65B | |
| -1.25% | +0.97% | -9.77% | -43.36% | 29.58B | |
| -1.65% | -0.39% | +67.06% | -8.64% | 25.31B | |
| -1.55% | -0.71% | -4.93% | -5.70% | 21.23B | |
| Average | -1.16% | +1.56% | +5.55% | -1.91% | 56.77B | |
| Weighted average by Cap. | -0.37% | +2.70% | -2.04% | +2.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.17B 3.61B 2.93B 2.69B 5.08B 348B 5.16B 34.96B 13.7B 171B 13.57B 13.27B 587B | 3.5B 3.99B 3.23B 2.97B 5.61B 385B 5.7B 38.6B 15.13B 188B 14.98B 14.65B 648B |
| Net income | 380M 434M 351M 323M 610M 41.85B 620M 4.2B 1.65B 20.48B 1.63B 1.59B 70.47B | 475M 542M 439M 404M 763M 52.29B 774M 5.25B 2.06B 25.59B 2.04B 1.99B 88.05B |
| Net Debt | 2.01B 2.3B 1.86B 1.71B 3.23B 222B 3.28B 22.23B 8.71B 108B 8.62B 8.44B 373B | 1.77B 2.02B 1.63B 1.5B 2.84B 195B 2.88B 19.53B 7.65B 95.27B 7.58B 7.41B 328B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | €180.20 | -2.96% | 55,079 |
| 26-07-17 | €185.70 | -0.91% | 107,069 |
| 26-07-16 | €187.40 | -0.85% | 65,344 |
| 26-07-15 | €189.00 | +0.27% | 52,185 |
| 26-07-14 | €188.50 | -0.42% | 69,084 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
